UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
WULF
TeraWulf Inc.
There isn't enough reported data to score WULF yet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
WULF Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| N/A | |
| N/A |
WULF's revenue is currently healthy, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like WULF.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
WULF PE Valuation
WULF has no meaningful PE right now: it lost money over the past year.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
WULF Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect WULF's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over WULF on earnings quality, reporting a profit while its opponent remains loss making.
WULF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.30 | -$1.87 |
| Q2 2026 | -$4.40 | -$4.04 |
| Q1 2026 | -$2.51 | -$2.17 |
| Q4 2025 | -$1.66 | -$1.45 |
| Q3 2025 | -$1.43 | -$1.29 |
| Q2 2025 | -$0.36 | -$0.19 |
| Q1 2025 | -$0.34 | -$0.12 |
| Q4 2024 | -$0.21 | +$0.14 |
WULF lost $3.30 per share over the past year, a bigger loss than the year before.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over WULF on profitability, with a higher operating margin.
WULF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $76.2M | +51% |
| Q2 2026 | $44.8M | -6% |
| Q1 2026 | $34M | -1.1% |
| Q4 2025 | $35.8M | +2.4% |
| Q3 2025 | $50.6M | +87% |
| Q2 2025 | $47.6M | +34% |
| Q1 2025 | $34.4M | -19% |
| Q4 2024 | $35M | +50% |
WULF's revenue is growing: $76M last quarter, up 51% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -116% | -67 points |
| Q2 2026 | -314% | -281 points |
| Q1 2026 | -477% | -303 points |
| Q4 2025 | -241% | -94 points |
| Q3 2025 | -49% | +9.3 points |
| Q2 2025 | -33% | -14 points |
| Q1 2025 | -173% | -168 points |
| Q4 2024 | -147% | -127 points |
WULF's operating margin was −116% last quarter, down 67 points from the same quarter a year ago.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over WULF on cash generation, producing positive trailing cash flow while its opponent burns cash.
WULF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$876.9M | -$608.7M |
| Q2 2026 | -$992.3M | -$817.5M |
| Q1 2026 | -$540.5M | -$503.3M |
| Q4 2025 | -$703.2M | -$506.8M |
| Q3 2025 | -$268.3M | -$226.6M |
| Q2 2025 | -$174.8M | -$144.5M |
| Q1 2025 | -$37.2M | -$13.1M |
| Q4 2024 | -$196.4M | -$173.5M |
WULF's free cash flow was −$3.1B over the past year, against −$677M the year before. Free cash flow isn't a meaningful measure for financial services companies like WULF.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over WULF on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
WULF Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +18% | +87.9M shares |
| 1 year | +43% | +172M shares |
| 3 years | +173% | +363M shares |
| 5 years | +28923% | +572M shares |
| Available history | +28866% | +572M shares |
WULF has 574M diluted shares, up 43% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $33.3M |
| Q4 2021 | — |
WULF hasn't bought back shares in the past year.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
WULF Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | -1.0x | Net Cash |
| Q2 2024 | -1.4x | Net Cash |
| Q1 2024 | 3.5x | Elevated |
| Q4 2021 | 32.9x | High |
WULF has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like WULF.
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
WULF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.6 | Neutral |
| Stochastic | 24.3 | Neutral |
WULF's weekly RSI is 41 (neutral) and its Stochastic is 24 (neutral).
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
WULF PE vs Financial Services Sector
| Metric | WULF | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
WULF has no meaningful PE right now: it lost money over the past year.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over WULF on trend strength, trading above more of its moving averages.
WULF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.0 | 0.2% above |
| 20 week MA | $15.9 | 18% below |
| 50 week MA | $17.1 | 24% below |
| 100 week MA | $11.9 | 9.7% above |
| 200 week MA | $7.29 | 79% above |
WULF's trend is mixed: it's above three of its five weekly moving averages, and 79% above its 200-week average.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over WULF on returns for 2026, with the stronger performance.
WULF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.42 | $6.48 | +20% |
| 2021 | $6.48 | $14.4 | +122% |
| 2022 | $14.4 | $0.77 | -95% |
| 2023 | $0.77 | $2.40 | +212% |
| 2024 | $2.40 | $5.53 | +130% |
| 2025 | $5.53 | $11.8 | +112% |
| 2026 YTD | $11.8 | $13.0 | +11% |
WULF's yearly returns have swung widely, from +212% in 2023 to −95% in 2022. It's up 11% so far in 2026.